𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intra-arterial (IAH) cisplatin for the treatment of liver malignancies-pharmacokinetics and pharmacodynamics

✍ Scribed by Gorodetsky, R; Vexler, A; Mou, X; Gabizon, A

Book ID
122523031
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
177 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Intra-arterial cisplatin for the treatme
Intra-arterial cisplatin for the treatment of malignant gliomas
✍ Herbert B. Newton; Michaelyn A. Page; Larry Junck; Harry S. Greenberg πŸ“‚ Article πŸ“… 1989 πŸ› Springer US 🌐 English βš– 571 KB

Cisplatin (DDP) is a chemotherapeutic agent that has shown efficacy against primary CNS malignancies. Intraarterial (IA) administration of DDP to patients with brain tumors should produce higher peak levels of drug than intravenous (IV) administration of an identical dose and reduce systemic toxicit

Reduction of the systemic toxicity of ci
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies
✍ Akiva M. Vexler; Xiaode Mou; Alberto A. Gabizon; Raphael Gorodetsky πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 572 KB

## Abstract Cisplatin (CDDP) administration by the intra‐arterial hepatic route (i.a.h.) in patients with primary or metastatic liver malignancies could enhance the anti‐tumor activity of the drug and reduce its systemic toxicity. The aim of the present study was to compare Pt pharmacokinetics and